| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.663 | 0.005 | 0.774 | Anticonvulsant | 0.774 0.004 DBMET01020 0.774 0.004 DBMET02802 0.258 0.054 DBMET02807 0.584 0.008 DBMET02803 0.584 0.008 DBMET02804 | DBMET02802 | |
| 0.451 | 0.041 | 0.451 | GABA C receptor rho-3 antagonist | 0.319 0.104 DBMET01020 0.319 0.104 DBMET02802 0.313 0.107 DBMET02807 0.44 0.045 DBMET02803 0.44 0.045 DBMET02804 | ||
| 0.444 | 0.037 | 0.444 | 5 Hydroxytryptamine release stimulant | 0.403 0.045 DBMET01020 0.403 0.045 DBMET02802 0.289 0.073 DBMET02808 0.407 0.044 DBMET02803 0.407 0.044 DBMET02804 0.439 0.038 DBMET02805 0.439 0.038 DBMET02806 | ||
| 0.409 | 0.005 | 0.409 | Interleukin 1 antagonist | 0.256 0.018 DBMET01020 0.256 0.018 DBMET02802 0.219 0.026 DBMET02807 0.243 0.02 DBMET02808 0.321 0.009 DBMET02803 0.321 0.009 DBMET02804 0.159 0.052 DBMET02805 0.159 0.052 DBMET02806 | ||
| 0.457 | 0.057 | 0.474 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.417 0.086 DBMET01020 0.417 0.086 DBMET02802 0.335 0.169 DBMET02807 0.474 0.046 DBMET02803 0.474 0.046 DBMET02804 | DBMET02804 | |
| 0.452 | 0.065 | 0.604 | Analgesic | 0.604 0.026 DBMET01020 0.604 0.026 DBMET02802 0.523 0.043 DBMET02803 0.523 0.043 DBMET02804 0.225 0.208 DBMET02805 0.225 0.208 DBMET02806 | DBMET02802 | |
| 0.396 | 0.017 | 0.528 | Anesthetic general | 0.485 0.009 DBMET01020 0.485 0.009 DBMET02802 0.156 0.108 DBMET02807 0.455 0.011 DBMET02808 0.528 0.006 DBMET02803 0.528 0.006 DBMET02804 0.511 0.007 DBMET02805 0.511 0.007 DBMET02806 | DBMET02804 | |
| 0.41 | 0.074 | 0.41 | Calcium channel L-type activator | 0.231 0.228 DBMET02807 0.257 0.197 DBMET02808 0.257 0.197 DBMET02803 0.257 0.197 DBMET02804 | ||
| 0.35 | 0.019 | 0.578 | Non-steroidal antiinflammatory agent | 0.198 0.073 DBMET01020 0.198 0.073 DBMET02802 0.162 0.102 DBMET02807 0.578 0.005 DBMET02808 0.216 0.059 DBMET02803 0.216 0.059 DBMET02804 0.394 0.014 DBMET02805 0.394 0.014 DBMET02806 | DBMET02808 | |
| 0.4 | 0.076 | 0.506 | Histamine release inhibitor | 0.216 0.185 DBMET01020 0.216 0.185 DBMET02802 0.215 0.185 DBMET02807 0.506 0.027 DBMET02808 0.25 0.155 DBMET02803 0.25 0.155 DBMET02804 0.486 0.034 DBMET02805 0.486 0.034 DBMET02806 | DBMET02808 | |
| 0.427 | 0.123 | 0.812 | Antiinflammatory | 0.66 0.039 DBMET01020 0.66 0.039 DBMET02802 0.632 0.045 DBMET02807 0.787 0.017 DBMET02808 0.624 0.047 DBMET02803 0.624 0.047 DBMET02804 0.812 0.014 DBMET02805 0.812 0.014 DBMET02806 | DBMET02806 | |
| 0.315 | 0.038 | 0.315 | 5 Hydroxytryptamine uptake stimulant | 0.256 0.075 DBMET01020 0.256 0.075 DBMET02802 0.295 0.048 DBMET02803 0.295 0.048 DBMET02804 | ||
| 0.295 | 0.036 | 0.295 | Tyrosine 3 hydroxylase inhibitor | 0.255 0.063 DBMET01020 0.255 0.063 DBMET02802 0.196 0.143 DBMET02807 0.284 0.042 DBMET02803 0.284 0.042 DBMET02804 | ||
| 0.305 | 0.047 | 0.376 | Interleukin antagonist | 0.233 0.068 DBMET01020 0.233 0.068 DBMET02802 0.232 0.069 DBMET02808 0.376 0.034 DBMET02803 0.376 0.034 DBMET02804 | DBMET02804 | |
| 0.292 | 0.046 | 0.498 | DNA synthesis inhibitor | 0.291 0.047 DBMET01020 0.291 0.047 DBMET02802 0.182 0.15 DBMET02807 0.498 0.014 DBMET02808 0.336 0.033 DBMET02803 0.336 0.033 DBMET02804 0.489 0.014 DBMET02805 0.489 0.014 DBMET02806 | DBMET02808 | |
| 0.321 | 0.083 | 0.626 | Angiogenesis inhibitor | 0.295 0.095 DBMET01020 0.295 0.095 DBMET02802 0.626 0.014 DBMET02807 0.49 0.031 DBMET02808 0.341 0.075 DBMET02803 0.341 0.075 DBMET02804 0.359 0.067 DBMET02805 0.359 0.067 DBMET02806 | DBMET02807 | |
| 0.223 | 0.034 | 0.223 | 5 Hydroxytryptamine 3E antagonist | 0.199 0.064 DBMET02807 0.171 0.131 DBMET02803 0.171 0.131 DBMET02804 | ||
| 0.238 | 0.05 | 0.389 | Peroxidase inhibitor | 0.216 0.055 DBMET01020 0.216 0.055 DBMET02802 0.175 0.067 DBMET02807 0.389 0.022 DBMET02803 0.389 0.022 DBMET02804 | DBMET02804 | |
| 0.253 | 0.076 | 0.279 | Gastrin inhibitor | 0.207 0.138 DBMET01020 0.207 0.138 DBMET02802 0.279 0.05 DBMET02803 0.279 0.05 DBMET02804 | DBMET02804 | |
| 0.217 | 0.04 | 0.217 | Heat shock protein 90 alpha antagonist | |||
| 0.248 | 0.077 | 0.248 | 5 Hydroxytryptamine 1E antagonist | 0.179 0.155 DBMET02807 | ||
| 0.191 | 0.023 | 0.191 | Butyrylcholinesterase inhibitor | 0.098 0.064 DBMET01020 0.098 0.064 DBMET02802 0.086 0.075 DBMET02803 0.086 0.075 DBMET02804 | ||
| 0.261 | 0.093 | 0.284 | Lipoxygenase inhibitor | 0.236 0.11 DBMET01020 0.236 0.11 DBMET02802 0.284 0.079 DBMET02803 0.284 0.079 DBMET02804 | DBMET02804 | |
| 0.314 | 0.149 | 0.473 | 5 Hydroxytryptamine release inhibitor | 0.473 0.042 DBMET02808 0.292 0.175 DBMET02803 0.292 0.175 DBMET02804 0.282 0.186 DBMET02805 0.282 0.186 DBMET02806 | DBMET02808 | |
| 0.205 | 0.04 | 0.266 | Lipid peroxidase inhibitor | 0.111 0.104 DBMET01020 0.111 0.104 DBMET02802 0.266 0.024 DBMET02808 0.135 0.079 DBMET02803 0.135 0.079 DBMET02804 0.232 0.031 DBMET02805 0.232 0.031 DBMET02806 | DBMET02808 | |
| 0.17 | 0.017 | 0.17 | Creatine kinase inhibitor | 0.16 0.02 DBMET01020 0.16 0.02 DBMET02802 0.106 0.053 DBMET02807 0.169 0.017 DBMET02803 0.169 0.017 DBMET02804 | ||
| 0.19 | 0.038 | 0.19 | Nav1.2 sodium channel blocker | 0.155 0.054 DBMET01020 0.155 0.054 DBMET02802 0.178 0.043 DBMET02807 0.18 0.042 DBMET02803 0.18 0.042 DBMET02804 | ||
| 0.234 | 0.086 | 0.319 | Superoxide dismutase inhibitor | 0.225 0.093 DBMET01020 0.225 0.093 DBMET02802 0.319 0.044 DBMET02807 0.297 0.051 DBMET02803 0.297 0.051 DBMET02804 | DBMET02807 | |
| 0.244 | 0.098 | 0.572 | Immunostimulant | 0.328 0.071 DBMET01020 0.328 0.071 DBMET02802 0.243 0.099 DBMET02807 0.549 0.023 DBMET02808 0.316 0.074 DBMET02803 0.316 0.074 DBMET02804 0.572 0.02 DBMET02805 0.572 0.02 DBMET02806 | DBMET02806 | |
| 0.318 | 0.175 | 0.347 | Caspase 9 stimulant | 0.263 0.238 DBMET01020 0.263 0.238 DBMET02802 0.347 0.148 DBMET02808 0.297 0.197 DBMET02803 0.297 0.197 DBMET02804 0.319 0.174 DBMET02805 0.319 0.174 DBMET02806 | DBMET02808 | |
| 0.215 | 0.084 | 0.215 | MAP kinase kinase 3 inhibitor | 0.192 0.146 DBMET01020 0.192 0.146 DBMET02802 0.196 0.135 DBMET02807 0.213 0.088 DBMET02803 0.213 0.088 DBMET02804 | ||
| 0.206 | 0.077 | 0.251 | Platelet aggregation inhibitor | 0.155 0.123 DBMET01020 0.155 0.123 DBMET02802 0.251 0.051 DBMET02808 0.182 0.095 DBMET02803 0.182 0.095 DBMET02804 | DBMET02808 | |
| 0.164 | 0.035 | 0.164 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.177 | 0.05 | 0.177 | Heat shock protein 90 antagonist | |||
| 0.175 | 0.05 | 0.175 | MAO inhibitor | |||
| 0.155 | 0.032 | 0.188 | GABA C receptor agonist | 0.156 0.032 DBMET01020 0.156 0.032 DBMET02802 0.188 0.023 DBMET02803 0.188 0.023 DBMET02804 | DBMET02804 | |
| 0.259 | 0.137 | 0.28 | Calcium channel activator | 0.28 0.113 DBMET01020 0.28 0.113 DBMET02802 0.268 0.126 DBMET02803 0.268 0.126 DBMET02804 | DBMET02802 | |
| 0.17 | 0.051 | 0.17 | GABA C receptor rho-2 antagonist | 0.124 0.118 DBMET01020 0.124 0.118 DBMET02802 0.158 0.064 DBMET02803 0.158 0.064 DBMET02804 | ||
| 0.207 | 0.09 | 0.248 | RNA-directed DNA polymerase inhibitor | 0.21 0.085 DBMET01020 0.21 0.085 DBMET02802 0.187 0.119 DBMET02807 0.192 0.112 DBMET02808 0.248 0.05 DBMET02803 0.248 0.05 DBMET02804 0.2 0.099 DBMET02805 0.2 0.099 DBMET02806 | DBMET02804 | |
| 0.161 | 0.047 | 0.161 | Sodium channel (voltage-gated) blocker | 0.153 0.052 DBMET02807 0.109 0.098 DBMET02803 0.109 0.098 DBMET02804 | ||
| 0.129 | 0.018 | 0.129 | Glutamate decarboxylase inhibitor | 0.069 0.056 DBMET01020 0.069 0.056 DBMET02802 0.093 0.034 DBMET02803 0.093 0.034 DBMET02804 | ||
| 0.161 | 0.05 | 0.178 | Sodium channel blocker | 0.178 0.041 DBMET02807 0.106 0.103 DBMET02803 0.106 0.103 DBMET02804 | DBMET02807 | |
| 0.159 | 0.049 | 0.181 | NADPH oxidase inhibitor | 0.162 0.048 DBMET01020 0.162 0.048 DBMET02802 0.171 0.044 DBMET02808 0.139 0.062 DBMET02803 0.139 0.062 DBMET02804 0.181 0.04 DBMET02805 0.181 0.04 DBMET02806 | DBMET02806 | |
| 0.146 | 0.038 | 0.146 | GABA receptor agonist | |||
| 0.2 | 0.094 | 0.334 | Cyclic AMP phosphodiesterase inhibitor | 0.334 0.03 DBMET02808 0.224 0.078 DBMET02805 0.224 0.078 DBMET02806 | DBMET02808 | |
| 0.135 | 0.029 | 0.135 | GABA C receptor rho-1 antagonist | 0.11 0.05 DBMET01020 0.11 0.05 DBMET02802 0.131 0.031 DBMET02803 0.131 0.031 DBMET02804 | ||
| 0.144 | 0.039 | 0.144 | 5 Hydroxytryptamine 3A agonist | 0.093 0.085 DBMET02803 0.093 0.085 DBMET02804 | ||
| 0.113 | 0.014 | 0.113 | Acetylcholine M5 receptor agonist | |||
| 0.139 | 0.044 | 0.139 | MAO A inhibitor | |||
| 0.135 | 0.043 | 0.135 | MAO B inhibitor | |||
| 0.174 | 0.085 | 0.184 | P-glycoprotein inhibitor | 0.184 0.076 DBMET01020 0.184 0.076 DBMET02802 0.175 0.085 DBMET02808 0.174 0.086 DBMET02803 0.174 0.086 DBMET02804 0.183 0.077 DBMET02805 0.183 0.077 DBMET02806 | DBMET02802 | |
| 0.098 | 0.016 | 0.3 | NMDA 2B receptor antagonist | 0.3 0.004 DBMET01020 0.3 0.004 DBMET02802 0.195 0.006 DBMET02807 0.284 0.004 DBMET02803 0.284 0.004 DBMET02804 | DBMET02802 | |
| 0.191 | 0.109 | 0.38 | Aldehyde oxidase inhibitor | 0.218 0.096 DBMET01020 0.218 0.096 DBMET02802 0.38 0.05 DBMET02803 0.38 0.05 DBMET02804 | DBMET02804 | |
| 0.127 | 0.046 | 0.141 | GABA C receptor antagonist | 0.118 0.055 DBMET01020 0.118 0.055 DBMET02802 0.098 0.08 DBMET02807 0.141 0.035 DBMET02803 0.141 0.035 DBMET02804 | DBMET02804 | |
| 0.09 | 0.017 | 0.09 | Glutamate (mGluR7) antagonist | 0.068 0.045 DBMET01020 0.068 0.045 DBMET02802 0.072 0.039 DBMET02807 0.088 0.019 DBMET02803 0.088 0.019 DBMET02804 | ||
| 0.112 | 0.04 | 0.114 | Glutamate (mGluR7) agonist | 0.114 0.037 DBMET01020 0.114 0.037 DBMET02802 0.112 0.04 DBMET02803 0.112 0.04 DBMET02804 | DBMET02802 | |
| 0.162 | 0.092 | 0.177 | Succinate dehydrogenase inhibitor | 0.149 0.115 DBMET01020 0.149 0.115 DBMET02802 0.177 0.071 DBMET02803 0.177 0.071 DBMET02804 | DBMET02804 | |
| 0.091 | 0.02 | 0.091 | Aminopeptidase microsomal inhibitor | |||
| 0.109 | 0.041 | 0.109 | NMDA receptor antagonist | 0.078 0.068 DBMET01020 0.078 0.068 DBMET02802 | ||
| 0.078 | 0.01 | 0.093 | Ryanodine receptor antagonist | 0.076 0.011 DBMET01020 0.076 0.011 DBMET02802 0.062 0.033 DBMET02807 0.093 0.005 DBMET02803 0.093 0.005 DBMET02804 | DBMET02804 | |
| 0.108 | 0.041 | 0.108 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.122 | 0.055 | 0.149 | Photosensitizer | 0.149 0.032 DBMET02808 0.109 0.073 DBMET02803 0.109 0.073 DBMET02804 0.116 0.062 DBMET02805 0.116 0.062 DBMET02806 | DBMET02808 | |
| 0.1 | 0.035 | 0.1 | Granulocyte macrophage colony stimulating factor agonist | 0.085 0.063 DBMET02807 0.084 0.065 DBMET02803 0.084 0.065 DBMET02804 | ||
| 0.085 | 0.022 | 0.085 | 5 Hydroxytryptamine 3 antagonist | 0.075 0.026 DBMET01020 0.075 0.026 DBMET02802 0.055 0.042 DBMET02803 0.055 0.042 DBMET02804 | ||
| 0.084 | 0.023 | 0.234 | Alcohol oxidase inhibitor | 0.15 0.01 DBMET01020 0.15 0.01 DBMET02802 0.234 0.005 DBMET02803 0.234 0.005 DBMET02804 | DBMET02804 | |
| 0.119 | 0.059 | 0.217 | Cystathionine beta-synthase inhibitor | 0.122 0.056 DBMET01020 0.122 0.056 DBMET02802 0.217 0.021 DBMET02808 0.184 0.029 DBMET02803 0.184 0.029 DBMET02804 0.096 0.081 DBMET02805 0.096 0.081 DBMET02806 | DBMET02808 | |
| 0.081 | 0.024 | 0.155 | Purinergic P2X1 antagonist | 0.117 0.012 DBMET01020 0.117 0.012 DBMET02802 0.057 0.049 DBMET02807 0.071 0.031 DBMET02808 0.155 0.006 DBMET02803 0.155 0.006 DBMET02804 0.055 0.051 DBMET02805 0.055 0.051 DBMET02806 | DBMET02804 | |
| 0.139 | 0.083 | 0.169 | Adenylate cyclase stimulant | 0.164 0.043 DBMET01020 0.164 0.043 DBMET02802 0.147 0.067 DBMET02807 0.169 0.036 DBMET02803 0.169 0.036 DBMET02804 | DBMET02804 | |
| 0.205 | 0.15 | 0.205 | Insulysin inhibitor | |||
| 0.153 | 0.101 | 0.193 | Phospholipase C inhibitor | 0.165 0.079 DBMET01020 0.165 0.079 DBMET02802 0.152 0.102 DBMET02807 0.146 0.115 DBMET02808 0.193 0.049 DBMET02803 0.193 0.049 DBMET02804 | DBMET02804 | |
| 0.123 | 0.071 | 0.127 | Cathepsin H inhibitor | 0.104 0.1 DBMET01020 0.104 0.1 DBMET02802 0.127 0.067 DBMET02803 0.127 0.067 DBMET02804 | DBMET02804 | |
| 0.106 | 0.055 | 0.115 | Anabolic | 0.115 0.044 DBMET01020 0.115 0.044 DBMET02802 0.11 0.05 DBMET02803 0.11 0.05 DBMET02804 | DBMET02802 | |
| 0.182 | 0.132 | 0.295 | DNA damaging | 0.295 0.059 DBMET02808 0.264 0.073 DBMET02803 0.264 0.073 DBMET02804 0.264 0.073 DBMET02805 0.264 0.073 DBMET02806 | DBMET02808 | |
| 0.107 | 0.057 | 0.231 | Adenylate kinase inhibitor | 0.157 0.024 DBMET01020 0.157 0.024 DBMET02802 0.112 0.052 DBMET02808 0.231 0.011 DBMET02803 0.231 0.011 DBMET02804 0.096 0.074 DBMET02805 0.096 0.074 DBMET02806 | DBMET02804 | |
| 0.118 | 0.07 | 0.349 | Alkylator | 0.164 0.04 DBMET01020 0.164 0.04 DBMET02802 0.159 0.042 DBMET02807 0.309 0.012 DBMET02808 0.187 0.03 DBMET02803 0.187 0.03 DBMET02804 0.349 0.01 DBMET02805 0.349 0.01 DBMET02806 | DBMET02806 | |
| 0.136 | 0.089 | 0.16 | Ca2+-transporting ATPase inhibitor | 0.152 0.038 DBMET01020 0.152 0.038 DBMET02802 0.138 0.083 DBMET02808 0.16 0.024 DBMET02803 0.16 0.024 DBMET02804 0.158 0.026 DBMET02805 0.158 0.026 DBMET02806 | DBMET02804 | |
| 0.068 | 0.021 | 0.068 | Aminopeptidase N inhibitor | |||
| 0.07 | 0.024 | 0.07 | NMDA 2A receptor antagonist | |||
| 0.163 | 0.119 | 0.221 | Neurotrophic factor enhancer | 0.192 0.084 DBMET01020 0.192 0.084 DBMET02802 0.221 0.058 DBMET02808 0.188 0.089 DBMET02803 0.188 0.089 DBMET02804 0.172 0.108 DBMET02805 0.172 0.108 DBMET02806 | DBMET02808 | |
| 0.087 | 0.043 | 0.102 | Porphobilinogen synthase inhibitor | 0.102 0.035 DBMET02803 0.102 0.035 DBMET02804 | DBMET02804 | |
| 0.1 | 0.057 | 0.148 | MAP kinase kinase 1 inhibitor | 0.13 0.027 DBMET01020 0.13 0.027 DBMET02802 0.148 0.017 DBMET02803 0.148 0.017 DBMET02804 | DBMET02804 | |
| 0.108 | 0.066 | 0.108 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.134 | 0.092 | 0.134 | Sphingosine 1-phosphate receptor 5 antagonist | 0.131 0.098 DBMET02803 0.131 0.098 DBMET02804 | ||
| 0.098 | 0.057 | 0.123 | HIV-1 integrase (Overall Integration) inhibitor | 0.087 0.069 DBMET01020 0.087 0.069 DBMET02802 0.123 0.038 DBMET02803 0.123 0.038 DBMET02804 | DBMET02804 | |
| 0.076 | 0.036 | 0.087 | Protein kinase C beta inhibitor | 0.084 0.025 DBMET01020 0.084 0.025 DBMET02802 0.087 0.022 DBMET02803 0.087 0.022 DBMET02804 | DBMET02804 | |
| 0.178 | 0.139 | 0.307 | Spasmolytic | 0.273 0.081 DBMET01020 0.273 0.081 DBMET02802 0.279 0.079 DBMET02808 0.201 0.118 DBMET02803 0.201 0.118 DBMET02804 0.307 0.067 DBMET02805 0.307 0.067 DBMET02806 | DBMET02806 | |
| 0.069 | 0.03 | 0.073 | Cyclin D1 inhibitor | 0.073 0.024 DBMET02803 0.073 0.024 DBMET02804 | DBMET02804 | |
| 0.105 | 0.066 | 0.105 | DOPA decarboxylase inhibitor | 0.103 0.07 DBMET02803 0.103 0.07 DBMET02804 | ||
| 0.114 | 0.077 | 0.177 | Aldehyde dehydrogenase inhibitor | 0.177 0.034 DBMET02808 0.119 0.072 DBMET02803 0.119 0.072 DBMET02804 | DBMET02808 | |
| 0.061 | 0.025 | 0.076 | Aconitate hydratase inhibitor | 0.061 0.025 DBMET01020 0.061 0.025 DBMET02802 0.076 0.015 DBMET02803 0.076 0.015 DBMET02804 | DBMET02804 | |
| 0.076 | 0.04 | 0.092 | Phospholipase D inhibitor | 0.08 0.034 DBMET01020 0.08 0.034 DBMET02802 0.083 0.03 DBMET02807 0.092 0.02 DBMET02803 0.092 0.02 DBMET02804 | DBMET02804 | |
| 0.098 | 0.063 | 0.276 | UDP-glucose 4-epimerase inhibitor | 0.142 0.032 DBMET01020 0.142 0.032 DBMET02802 0.276 0.012 DBMET02808 0.198 0.018 DBMET02803 0.198 0.018 DBMET02804 0.245 0.014 DBMET02805 0.245 0.014 DBMET02806 | DBMET02808 | |
| 0.125 | 0.092 | 0.125 | Cyclooxygenase inhibitor | |||
| 0.102 | 0.069 | 0.167 | Ferrochelatase inhibitor | 0.098 0.073 DBMET01020 0.098 0.073 DBMET02802 0.167 0.031 DBMET02803 0.167 0.031 DBMET02804 | DBMET02804 | |
| 0.077 | 0.044 | 0.121 | Histidine decarboxylase inhibitor | 0.105 0.03 DBMET01020 0.105 0.03 DBMET02802 0.121 0.025 DBMET02803 0.121 0.025 DBMET02804 | DBMET02804 | |
| 0.136 | 0.104 | 0.154 | CF transmembrane conductance regulator agonist | 0.154 0.069 DBMET02803 0.154 0.069 DBMET02804 | DBMET02804 | |
| 0.103 | 0.072 | 0.128 | Nav1.4 sodium channel blocker | 0.108 0.064 DBMET01020 0.108 0.064 DBMET02802 0.128 0.046 DBMET02807 0.127 0.046 DBMET02803 0.127 0.046 DBMET02804 | DBMET02807 | |
| 0.144 | 0.112 | 0.144 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.063 | 0.035 | 0.123 | Argininosuccinate synthase inhibitor | 0.089 0.022 DBMET01020 0.089 0.022 DBMET02802 0.123 0.015 DBMET02803 0.123 0.015 DBMET02804 | DBMET02804 | |
| 0.031 | 0.004 | 0.031 | Complement factor D inhibitor | 0.023 0.005 DBMET01020 0.023 0.005 DBMET02802 0.017 0.016 DBMET02807 0.027 0.005 DBMET02803 0.027 0.005 DBMET02804 | ||
| 0.063 | 0.036 | 0.063 | Heat shock protein 90 beta antagonist | |||
| 0.132 | 0.106 | 0.201 | Interferon gamma antagonist | 0.134 0.103 DBMET01020 0.134 0.103 DBMET02802 0.201 0.04 DBMET02808 0.132 0.108 DBMET02803 0.132 0.108 DBMET02804 0.201 0.04 DBMET02805 0.201 0.04 DBMET02806 | DBMET02806 | |
| 0.074 | 0.049 | 0.088 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.075 0.049 DBMET01020 0.075 0.049 DBMET02802 0.088 0.024 DBMET02803 0.088 0.024 DBMET02804 | DBMET02804 | |
| 0.05 | 0.025 | 0.051 | Purinergic P2X4 antagonist | 0.051 0.023 DBMET02803 0.051 0.023 DBMET02804 | DBMET02804 | |
| 0.093 | 0.068 | 0.093 | Platelet activating factor beta antagonist | |||
| 0.104 | 0.081 | 0.188 | TRPA1 agonist | 0.188 0.013 DBMET02807 | DBMET02807 | |
| 0.087 | 0.064 | 0.178 | Triose-phosphate isomerase inhibitor | 0.11 0.039 DBMET01020 0.11 0.039 DBMET02802 0.123 0.031 DBMET02807 0.178 0.014 DBMET02808 0.154 0.019 DBMET02803 0.154 0.019 DBMET02804 0.158 0.018 DBMET02805 0.158 0.018 DBMET02806 | DBMET02808 | |
| 0.043 | 0.021 | 0.043 | Vascular adhesion protein 1 inhibitor | 0.038 0.028 DBMET01020 0.038 0.028 DBMET02802 0.041 0.025 DBMET02803 0.041 0.025 DBMET02804 | ||
| 0.089 | 0.068 | 0.11 | Prolactin inhibitor | 0.091 0.066 DBMET01020 0.091 0.066 DBMET02802 0.11 0.046 DBMET02803 0.11 0.046 DBMET02804 | DBMET02804 | |
| 0.062 | 0.041 | 0.145 | Carbamoyl phosphate synthetase inhibitor | 0.113 0.017 DBMET01020 0.113 0.017 DBMET02802 0.145 0.012 DBMET02803 0.145 0.012 DBMET02804 | DBMET02804 | |
| 0.04 | 0.022 | 0.096 | Kinesin-like protein 1 inhibitor | 0.096 0.008 DBMET02807 | DBMET02807 | |
| 0.04 | 0.022 | 0.096 | Kinesin antagonist | 0.096 0.008 DBMET02807 | DBMET02807 | |
| 0.087 | 0.069 | 0.179 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.127 0.035 DBMET01020 0.127 0.035 DBMET02802 0.148 0.027 DBMET02808 0.179 0.019 DBMET02803 0.179 0.019 DBMET02804 0.139 0.03 DBMET02805 0.139 0.03 DBMET02806 | DBMET02804 | |
| 0.079 | 0.064 | 0.079 | Caspase 7 inhibitor | |||
| 0.083 | 0.068 | 0.207 | NADH dehydrogenase inhibitor | 0.118 0.03 DBMET01020 0.118 0.03 DBMET02802 0.207 0.01 DBMET02808 0.164 0.015 DBMET02803 0.164 0.015 DBMET02804 0.171 0.014 DBMET02805 0.171 0.014 DBMET02806 | DBMET02808 | |
| 0.053 | 0.04 | 0.053 | GABA receptor antagonist | |||
| 0.188 | 0.176 | 0.602 | Cholesterol antagonist | 0.299 0.092 DBMET01020 0.299 0.092 DBMET02802 0.446 0.041 DBMET02808 0.274 0.109 DBMET02803 0.274 0.109 DBMET02804 0.602 0.018 DBMET02805 0.602 0.018 DBMET02806 | DBMET02806 | |
| 0.125 | 0.113 | 0.169 | Growth hormone agonist | 0.169 0.074 DBMET01020 0.169 0.074 DBMET02802 0.146 0.09 DBMET02803 0.146 0.09 DBMET02804 | DBMET02802 | |
| 0.096 | 0.085 | 0.105 | Protein kinase C gamma inhibitor | 0.105 0.069 DBMET01020 0.105 0.069 DBMET02802 0.102 0.074 DBMET02803 0.102 0.074 DBMET02804 | DBMET02802 | |
| 0.061 | 0.051 | 0.061 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.064 | 0.054 | 0.083 | Glutamate (mGluR6) antagonist | 0.074 0.032 DBMET01020 0.074 0.032 DBMET02802 0.083 0.021 DBMET02803 0.083 0.021 DBMET02804 | DBMET02804 | |
| 0.043 | 0.034 | 0.043 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.102 | 0.094 | 0.102 | Glutamate receptor antagonist | |||
| 0.074 | 0.066 | 0.135 | Glycine receptor antagonist | 0.118 0.019 DBMET01020 0.118 0.019 DBMET02802 0.091 0.042 DBMET02807 0.135 0.011 DBMET02808 0.105 0.028 DBMET02803 0.105 0.028 DBMET02804 0.132 0.013 DBMET02805 0.132 0.013 DBMET02806 | DBMET02808 | |
| 0.043 | 0.036 | 0.043 | Farnesyltransferase inhibitor | |||
| 0.061 | 0.054 | 0.063 | Calcium channel P-type blocker | 0.06 0.056 DBMET01020 0.06 0.056 DBMET02802 0.063 0.048 DBMET02803 0.063 0.048 DBMET02804 | DBMET02804 | |
| 0.03 | 0.024 | 0.03 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.076 | 0.07 | 0.093 | Inducible nitric-oxide synthase inhibitor | 0.093 0.044 DBMET01020 0.093 0.044 DBMET02802 | DBMET02802 | |
| 0.098 | 0.093 | 0.113 | Acetylcholine release stimulant | 0.113 0.06 DBMET02805 0.113 0.06 DBMET02806 | DBMET02806 | |
| 0.115 | 0.11 | 0.12 | Sphingosine 1-phosphate receptor 2 antagonist | 0.12 0.096 DBMET02803 0.12 0.096 DBMET02804 | DBMET02804 | |
| 0.048 | 0.043 | 0.048 | GABA A receptor antagonist | |||
| 0.066 | 0.062 | 0.125 | Glycine receptor agonist | 0.125 0.011 DBMET01020 0.125 0.011 DBMET02802 0.105 0.018 DBMET02803 0.105 0.018 DBMET02804 0.115 0.014 DBMET02805 0.115 0.014 DBMET02806 | DBMET02802 | |
| 0.085 | 0.081 | 0.264 | Xanthine oxidase inhibitor | 0.264 0.011 DBMET02808 0.091 0.07 DBMET02803 0.091 0.07 DBMET02804 0.137 0.04 DBMET02805 0.137 0.04 DBMET02806 | DBMET02808 | |
| 0.091 | 0.087 | 0.091 | Platelet activating factor antagonist | |||
| 0.041 | 0.041 | 0.057 | Adenylate cyclase 1 inhibitor | 0.055 0.022 DBMET01020 0.055 0.022 DBMET02802 0.057 0.02 DBMET02803 0.057 0.02 DBMET02804 | DBMET02804 | |
| 0.051 | 0.055 | 0.086 | Androgen agonist | 0.086 0.021 DBMET01020 0.086 0.021 DBMET02802 0.068 0.032 DBMET02803 0.068 0.032 DBMET02804 | DBMET02802 | |
| 0.076 | 0.082 | 0.091 | D-Ala-D-Ala ligase inhibitor | 0.091 0.044 DBMET02803 0.091 0.044 DBMET02804 | DBMET02804 | |
| 0.047 | 0.054 | 0.135 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.088 0.017 DBMET01020 0.088 0.017 DBMET02802 0.092 0.016 DBMET02808 0.135 0.01 DBMET02803 0.135 0.01 DBMET02804 0.072 0.025 DBMET02805 0.072 0.025 DBMET02806 | DBMET02804 | |
| 0.071 | 0.078 | 0.088 | MAP kinase kinase 7 inhibitor | 0.079 0.048 DBMET01020 0.079 0.048 DBMET02802 0.088 0.028 DBMET02803 0.088 0.028 DBMET02804 | DBMET02804 | |
| 0.098 | 0.105 | 0.305 | Alpha-N-acetylglucosaminidase inhibitor | 0.222 0.028 DBMET01020 0.222 0.028 DBMET02802 0.241 0.024 DBMET02808 0.305 0.016 DBMET02803 0.305 0.016 DBMET02804 0.254 0.022 DBMET02805 0.254 0.022 DBMET02806 | DBMET02804 | |
| 0.033 | 0.04 | 0.036 | Dopamine D5 agonist | 0.036 0.034 DBMET02803 0.036 0.034 DBMET02804 | DBMET02804 | |
| 0.031 | 0.039 | 0.057 | Adenosine uptake inhibitor | 0.057 0.004 DBMET02807 | DBMET02807 | |
| 0.062 | 0.071 | 0.123 | Glutamate dehydrogenase inhibitor | 0.09 0.036 DBMET01020 0.09 0.036 DBMET02802 0.123 0.022 DBMET02803 0.123 0.022 DBMET02804 | DBMET02804 | |
| 0.13 | 0.14 | 0.185 | Lipocortins synthesis antagonist | 0.176 0.074 DBMET01020 0.176 0.074 DBMET02802 0.14 0.121 DBMET02808 0.185 0.067 DBMET02803 0.185 0.067 DBMET02804 | DBMET02804 | |
| 0.082 | 0.092 | 0.092 | Nitric-oxide synthase inhibitor | 0.092 0.075 DBMET01020 0.092 0.075 DBMET02802 | DBMET02802 | |
| 0.117 | 0.131 | 0.169 | Arachidonic acid antagonist | 0.148 0.091 DBMET01020 0.148 0.091 DBMET02802 0.169 0.066 DBMET02803 0.169 0.066 DBMET02804 | DBMET02804 | |
| 0.061 | 0.077 | 0.077 | Analgesic, opioid | 0.077 0.052 DBMET01020 0.077 0.052 DBMET02802 | DBMET02802 | |
| 0.051 | 0.067 | 0.187 | Phosphofructokinase-1 inhibitor | 0.101 0.031 DBMET01020 0.101 0.031 DBMET02802 0.157 0.017 DBMET02808 0.135 0.021 DBMET02803 0.135 0.021 DBMET02804 0.187 0.012 DBMET02805 0.187 0.012 DBMET02806 | DBMET02806 | |
| 0.031 | 0.048 | 0.037 | Glutamate (mGluR8) agonist | 0.037 0.027 DBMET02803 0.037 0.027 DBMET02804 | DBMET02804 | |
| 0.113 | 0.13 | 0.283 | Hexokinase inhibitor | 0.283 0.012 DBMET02808 0.148 0.081 DBMET02803 0.148 0.081 DBMET02804 0.184 0.046 DBMET02805 0.184 0.046 DBMET02806 | DBMET02808 | |
| 0.034 | 0.053 | 0.049 | Kainate receptor agonist | 0.042 0.026 DBMET01020 0.042 0.026 DBMET02802 0.049 0.015 DBMET02803 0.049 0.015 DBMET02804 | DBMET02804 | |
| 0.045 | 0.063 | 0.136 | Biliverdin reductase inhibitor | 0.085 0.024 DBMET01020 0.085 0.024 DBMET02802 0.136 0.011 DBMET02803 0.136 0.011 DBMET02804 | DBMET02804 | |
| 0.053 | 0.072 | 0.1 | NMDA 2 receptor antagonist | 0.1 0.032 DBMET01020 0.1 0.032 DBMET02802 0.069 0.052 DBMET02803 0.069 0.052 DBMET02804 | DBMET02802 | |
| 0.107 | 0.127 | 0.169 | Mannose-6-phosphate isomerase inhibitor | 0.169 0.049 DBMET02808 0.156 0.06 DBMET02803 0.156 0.06 DBMET02804 | DBMET02808 | |
| 0.061 | 0.081 | 0.073 | GABA aminotransferase inhibitor | 0.073 0.057 DBMET02803 0.073 0.057 DBMET02804 | DBMET02804 | |
| 0.056 | 0.077 | 0.087 | Aminopeptidase I inhibitor | 0.07 0.053 DBMET01020 0.07 0.053 DBMET02802 0.087 0.036 DBMET02803 0.087 0.036 DBMET02804 | DBMET02804 | |
| 0.031 | 0.053 | 0.04 | Guanylate cyclase inhibitor | 0.04 0.033 DBMET02808 | DBMET02808 | |
| 0.021 | 0.049 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.022 DBMET02803 0.026 0.022 DBMET02804 | DBMET02804 | |
| 0.142 | 0.17 | 0.233 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.174 0.102 DBMET01020 0.174 0.102 DBMET02802 0.233 0.051 DBMET02803 0.233 0.051 DBMET02804 | DBMET02804 | |
| 0.051 | 0.084 | 0.079 | Interferon inducer | 0.061 0.052 DBMET01020 0.061 0.052 DBMET02802 0.079 0.025 DBMET02808 0.067 0.04 DBMET02803 0.067 0.04 DBMET02804 0.069 0.036 DBMET02805 0.069 0.036 DBMET02806 | DBMET02808 | |
| 0.061 | 0.097 | 0.083 | Histamine N-methyltransferase inhibitor | 0.083 0.063 DBMET02803 0.083 0.063 DBMET02804 | DBMET02804 | |
| 0.075 | 0.111 | 0.085 | Electrolyte absorption antagonist | 0.085 0.084 DBMET02803 0.085 0.084 DBMET02804 | DBMET02804 | |
| 0.01 | 0.047 | 0.02 | Telomerase stimulant | 0.016 0.013 DBMET02808 0.02 0.008 DBMET02805 0.02 0.008 DBMET02806 | DBMET02806 | |
| 0.065 | 0.102 | 0.105 | Aminopeptidase B inhibitor | 0.104 0.063 DBMET02807 0.105 0.062 DBMET02803 0.105 0.062 DBMET02804 | DBMET02804 | |
| 0.053 | 0.093 | 0.059 | Prolactin release inhibitor | 0.059 0.056 DBMET01020 0.059 0.056 DBMET02802 | DBMET02802 | |
| 0.045 | 0.086 | 0.107 | Phenylalanine 4-hydroxylase inhibitor | 0.065 0.052 DBMET01020 0.065 0.052 DBMET02802 0.107 0.023 DBMET02803 0.107 0.023 DBMET02804 | DBMET02804 | |
| 0.019 | 0.059 | 0.05 | Fumarate hydratase inhibitor | 0.034 0.024 DBMET01020 0.034 0.024 DBMET02802 0.05 0.013 DBMET02803 0.05 0.013 DBMET02804 | DBMET02804 | |
| 0.058 | 0.1 | 0.1 | Interferon agonist | 0.071 0.068 DBMET01020 0.071 0.068 DBMET02802 0.1 0.028 DBMET02808 0.079 0.053 DBMET02803 0.079 0.053 DBMET02804 0.083 0.047 DBMET02805 0.083 0.047 DBMET02806 | DBMET02808 | |
| 0.113 | 0.155 | 0.164 | Psychostimulant | 0.151 0.115 DBMET01020 0.151 0.115 DBMET02802 0.154 0.113 DBMET02808 0.164 0.104 DBMET02805 0.164 0.104 DBMET02806 | DBMET02806 | |
| 0.071 | 0.114 | 0.115 | Protein kinase C zeta inhibitor | 0.115 0.036 DBMET02807 | DBMET02807 | |
| 0.093 | 0.137 | 0.352 | Protein kinase stimulant | 0.189 0.046 DBMET01020 0.189 0.046 DBMET02802 0.193 0.044 DBMET02808 0.154 0.066 DBMET02803 0.154 0.066 DBMET02804 0.352 0.012 DBMET02805 0.352 0.012 DBMET02806 | DBMET02806 | |
| 0.066 | 0.111 | 0.139 | Mediator release inhibitor | 0.139 0.034 DBMET02808 0.107 0.062 DBMET02805 0.107 0.062 DBMET02806 | DBMET02808 | |
| 0.019 | 0.066 | 0.024 | Complement factor 1s inhibitor | 0.024 0.021 DBMET02807 | DBMET02807 | |
| 0.103 | 0.152 | 0.174 | Cyclin-dependent kinase 8 inhibitor | 0.14 0.089 DBMET01020 0.14 0.089 DBMET02802 0.174 0.057 DBMET02803 0.174 0.057 DBMET02804 | DBMET02804 | |
| 0.033 | 0.083 | 0.059 | Glucose-6-phosphate isomerase inhibitor | 0.048 0.032 DBMET01020 0.048 0.032 DBMET02802 0.058 0.02 DBMET02808 0.059 0.019 DBMET02803 0.059 0.019 DBMET02804 0.055 0.023 DBMET02805 0.055 0.023 DBMET02806 | DBMET02804 | |
| 0.036 | 0.087 | 0.051 | Cytokine production stimulant | 0.051 0.027 DBMET02808 0.051 0.027 DBMET02805 0.051 0.027 DBMET02806 | DBMET02806 | |
| 0.013 | 0.064 | 0.042 | Acetylcholine M4 receptor agonist | 0.042 0.014 DBMET01020 0.042 0.014 DBMET02802 | DBMET02802 | |
| 0.079 | 0.133 | 0.115 | Microtubule formation inhibitor | 0.106 0.079 DBMET02808 0.115 0.067 DBMET02803 0.115 0.067 DBMET02804 0.112 0.071 DBMET02805 0.112 0.071 DBMET02806 | DBMET02804 | |
| 0.189 | 0.243 | 0.619 | Antibacterial | 0.225 0.201 DBMET01020 0.225 0.201 DBMET02802 0.284 0.148 DBMET02807 0.617 0.017 DBMET02808 0.274 0.155 DBMET02803 0.274 0.155 DBMET02804 0.619 0.016 DBMET02805 0.619 0.016 DBMET02806 | DBMET02806 | |
| 0.077 | 0.131 | 0.136 | MAP kinase kinase inhibitor | 0.107 0.087 DBMET01020 0.107 0.087 DBMET02802 0.136 0.06 DBMET02803 0.136 0.06 DBMET02804 | DBMET02804 | |
| 0.13 | 0.184 | 0.389 | Interleukin agonist | 0.241 0.086 DBMET01020 0.241 0.086 DBMET02802 0.313 0.042 DBMET02808 0.241 0.086 DBMET02803 0.241 0.086 DBMET02804 0.389 0.02 DBMET02805 0.389 0.02 DBMET02806 | DBMET02806 | |
| 0.03 | 0.085 | 0.09 | Acyl-CoA dehydrogenase inhibitor | 0.057 0.035 DBMET01020 0.057 0.035 DBMET02802 0.09 0.019 DBMET02803 0.09 0.019 DBMET02804 | DBMET02804 | |
| 0.027 | 0.082 | 0.039 | Thymidine kinase inhibitor | 0.039 0.031 DBMET02803 0.039 0.031 DBMET02804 | DBMET02804 | |
| 0.024 | 0.079 | 0.087 | Antibiotic Aminoglycoside-like | 0.037 0.024 DBMET01020 0.037 0.024 DBMET02802 0.08 0.004 DBMET02808 0.04 0.021 DBMET02803 0.04 0.021 DBMET02804 0.087 0.004 DBMET02805 0.087 0.004 DBMET02806 | DBMET02806 | |
| 0.011 | 0.067 | 0.03 | Antibiotic Anthracycline-like | 0.022 0.008 DBMET02808 0.03 0.004 DBMET02805 0.03 0.004 DBMET02806 | DBMET02806 | |
| 0.025 | 0.085 | 0.065 | Ornithine carbamoyltransferase inhibitor | 0.046 0.044 DBMET01020 0.046 0.044 DBMET02802 0.065 0.028 DBMET02803 0.065 0.028 DBMET02804 | DBMET02804 | |
| 0.017 | 0.077 | 0.036 | Purinergic P2Y15 antagonist | 0.03 0.017 DBMET01020 0.03 0.017 DBMET02802 0.036 0.01 DBMET02803 0.036 0.01 DBMET02804 | DBMET02804 | |
| 0.131 | 0.191 | 0.557 | Antioxidant | 0.17 0.142 DBMET01020 0.17 0.142 DBMET02802 0.181 0.131 DBMET02807 0.557 0.014 DBMET02808 0.479 0.023 DBMET02805 0.479 0.023 DBMET02806 | DBMET02808 | |
| 0.042 | 0.105 | 0.104 | Na+ K+ transporting ATPase inhibitor | 0.073 0.057 DBMET01020 0.073 0.057 DBMET02802 0.098 0.033 DBMET02808 0.076 0.054 DBMET02803 0.076 0.054 DBMET02804 0.104 0.028 DBMET02805 0.104 0.028 DBMET02806 | DBMET02806 | |
| 0.015 | 0.079 | 0.032 | Vanilloid 2 agonist | 0.026 0.016 DBMET02807 0.032 0.008 DBMET02808 0.028 0.013 DBMET02805 0.028 0.013 DBMET02806 | DBMET02808 | |
| 0.149 | 0.215 | 0.21 | Nitric-oxide synthase stimulant | 0.17 0.153 DBMET01020 0.17 0.153 DBMET02802 0.204 0.082 DBMET02808 0.21 0.074 DBMET02803 0.21 0.074 DBMET02804 0.168 0.157 DBMET02805 0.168 0.157 DBMET02806 | DBMET02804 | |
| 0.052 | 0.123 | 0.069 | Keratolytic | 0.069 0.067 DBMET02803 0.069 0.067 DBMET02804 | DBMET02804 | |
| 0.014 | 0.09 | 0.078 | Vasopressin 2 antagonist | 0.078 0.008 DBMET01020 0.078 0.008 DBMET02802 0.046 0.015 DBMET02803 0.046 0.015 DBMET02804 | DBMET02802 | |
| 0.057 | 0.134 | 0.118 | Alcohol dehydrogenase inhibitor | 0.118 0.036 DBMET02808 0.085 0.072 DBMET02803 0.085 0.072 DBMET02804 | DBMET02808 | |
| 0.086 | 0.163 | 0.103 | Transcription factor STAT6 inhibitor | 0.103 0.099 DBMET02803 0.103 0.099 DBMET02804 | DBMET02804 | |
| 0.009 | 0.088 | 0.028 | Uridine phosphorylase inhibitor | 0.028 0.019 DBMET02803 0.028 0.019 DBMET02804 | DBMET02804 | |
| 0.017 | 0.096 | 0.039 | Purinergic P2Y antagonist | 0.039 0.038 DBMET02803 0.039 0.038 DBMET02804 | DBMET02804 | |
| 0.012 | 0.091 | 0.066 | Protein 30S ribosomal subunit inhibitor | 0.057 0.007 DBMET02808 0.066 0.005 DBMET02805 0.066 0.005 DBMET02806 | DBMET02806 | |
| 0.064 | 0.144 | 0.106 | Adenylate cyclase inhibitor | 0.106 0.079 DBMET02803 0.106 0.079 DBMET02804 | DBMET02804 | |
| 0.075 | 0.156 | 0.303 | Cyclooxygenase 3 inhibitor | 0.11 0.09 DBMET01020 0.11 0.09 DBMET02802 0.243 0.009 DBMET02808 0.103 0.098 DBMET02803 0.103 0.098 DBMET02804 0.303 0.006 DBMET02805 0.303 0.006 DBMET02806 | DBMET02806 | |
| 0.067 | 0.151 | 0.277 | Beta glucuronidase inhibitor | 0.277 0.007 DBMET02808 0.121 0.045 DBMET02805 0.121 0.045 DBMET02806 | DBMET02808 | |
| 0.103 | 0.187 | 0.43 | Hepatoprotectant | 0.191 0.071 DBMET01020 0.191 0.071 DBMET02802 0.43 0.011 DBMET02808 0.173 0.086 DBMET02803 0.173 0.086 DBMET02804 0.421 0.012 DBMET02805 0.421 0.012 DBMET02806 | DBMET02808 | |
| 0.118 | 0.202 | 0.145 | Heat shock protein 70 antagonist | 0.145 0.058 DBMET02808 0.139 0.08 DBMET02803 0.139 0.08 DBMET02804 | DBMET02808 | |
| 0.053 | 0.137 | 0.096 | Falcipain 2 inhibitor | 0.096 0.055 DBMET02808 | DBMET02808 | |
| 0.055 | 0.14 | 0.071 | GABA B receptor agonist | 0.071 0.065 DBMET02803 0.071 0.065 DBMET02804 | DBMET02804 | |
| 0.067 | 0.152 | 0.113 | Mucolytic | 0.096 0.084 DBMET02803 0.096 0.084 DBMET02804 0.113 0.061 DBMET02805 0.113 0.061 DBMET02806 | DBMET02806 | |
| 0.055 | 0.141 | 0.098 | Falcipain inhibitor | 0.098 0.056 DBMET02808 | DBMET02808 | |
| 0.039 | 0.127 | 0.083 | Cathepsin G inhibitor | 0.083 0.042 DBMET02807 | DBMET02807 | |
| 0.021 | 0.11 | 0.047 | Leukocyte elastase inhibitor | 0.047 0.026 DBMET02807 | DBMET02807 | |
| 0.007 | 0.1 | 0.046 | Arginase inhibitor | 0.044 0.019 DBMET02808 0.046 0.017 DBMET02805 0.046 0.017 DBMET02806 | DBMET02806 | |
| 0.098 | 0.192 | 0.198 | Melanin inhibitor | 0.198 0.042 DBMET02808 0.164 0.065 DBMET02805 0.164 0.065 DBMET02806 | DBMET02808 | |
| 0.03 | 0.127 | 0.276 | Antineoplastic antibiotic | 0.174 0.026 DBMET02808 0.276 0.011 DBMET02805 0.276 0.011 DBMET02806 | DBMET02806 | |
| 0.031 | 0.131 | 0.053 | Sphingosine kinase 2 inhibitor | 0.053 0.041 DBMET02803 0.053 0.041 DBMET02804 | DBMET02804 | |
| 0.088 | 0.19 | 0.189 | DNA repair enzyme inhibitor | 0.179 0.014 DBMET02808 0.107 0.105 DBMET02803 0.107 0.105 DBMET02804 0.189 0.011 DBMET02805 0.189 0.011 DBMET02806 | DBMET02806 | |
| 0.017 | 0.12 | 0.076 | Phosphorylase inhibitor | 0.054 0.028 DBMET01020 0.054 0.028 DBMET02802 0.076 0.018 DBMET02808 0.043 0.034 DBMET02803 0.043 0.034 DBMET02804 0.069 0.021 DBMET02805 0.069 0.021 DBMET02806 | DBMET02808 | |
| 0.119 | 0.225 | 0.292 | Cardiotonic | 0.292 0.06 DBMET01020 0.292 0.06 DBMET02802 0.166 0.156 DBMET02805 0.166 0.156 DBMET02806 | DBMET02802 | |
| 0.088 | 0.199 | 0.134 | Vanilloid 1 agonist | 0.134 0.059 DBMET02807 | DBMET02807 | |
| 0.018 | 0.128 | 0.057 | Adenosine deaminase inhibitor | 0.057 0.023 DBMET02803 0.057 0.023 DBMET02804 | DBMET02804 | |
| 0.041 | 0.156 | 0.226 | Monophenol monooxygenase inhibitor | 0.226 0.027 DBMET02808 0.132 0.054 DBMET02805 0.132 0.054 DBMET02806 | DBMET02808 | |
| 0.028 | 0.143 | 0.063 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.063 0.037 DBMET02808 | DBMET02808 | |
| 0.017 | 0.135 | 0.026 | Hedgehog signaling activator | 0.026 0.025 DBMET01020 0.026 0.025 DBMET02802 | DBMET02802 | |
| 0.06 | 0.179 | 0.078 | Estrogen-related receptor beta agonist | 0.078 0.073 DBMET02803 0.078 0.073 DBMET02804 | DBMET02804 | |
| 0.091 | 0.212 | 0.171 | MAP kinase kinase 2 inhibitor | 0.171 0.103 DBMET01020 0.171 0.103 DBMET02802 0.171 0.103 DBMET02803 0.171 0.103 DBMET02804 | DBMET02804 | |
| 0.156 | 0.282 | 0.449 | Interleukin 2 agonist | 0.345 0.048 DBMET01020 0.345 0.048 DBMET02802 0.415 0.023 DBMET02808 0.279 0.09 DBMET02803 0.279 0.09 DBMET02804 0.449 0.016 DBMET02805 0.449 0.016 DBMET02806 | DBMET02806 | |
| 0.023 | 0.152 | 0.035 | Glucose-6-phosphate dehydrogenase inhibitor | 0.035 0.034 DBMET01020 0.035 0.034 DBMET02802 | DBMET02802 | |
| 0.086 | 0.216 | 0.338 | Nitric oxide antagonist | 0.134 0.112 DBMET01020 0.134 0.112 DBMET02802 0.338 0.034 DBMET02808 0.32 0.037 DBMET02805 0.32 0.037 DBMET02806 | DBMET02808 | |
| 0.047 | 0.18 | 0.229 | Expectorant | 0.21 0.018 DBMET02808 0.229 0.015 DBMET02805 0.229 0.015 DBMET02806 | DBMET02806 | |
| 0.076 | 0.213 | 0.277 | Cell wall synthesis inhibitor | 0.153 0.063 DBMET02807 0.277 0.012 DBMET02808 0.134 0.081 DBMET02803 0.134 0.081 DBMET02804 0.223 0.022 DBMET02805 0.223 0.022 DBMET02806 | DBMET02808 | |
| 0.004 | 0.147 | 0.036 | Estrone sulfatase inhibitor | 0.036 0.009 DBMET02807 | DBMET02807 | |
| 0.024 | 0.168 | 0.049 | Leukotriene B4 antagonist | 0.049 0.046 DBMET02808 | DBMET02808 | |
| 0.038 | 0.185 | 0.225 | Topoisomerase I inhibitor | 0.225 0.021 DBMET02808 0.221 0.022 DBMET02805 0.221 0.022 DBMET02806 | DBMET02808 | |
| 0.091 | 0.239 | 0.134 | Pregnane X receptor agonist | 0.134 0.089 DBMET02807 | DBMET02807 | |
| 0.005 | 0.155 | 0.112 | Cholecystokinin B antagonist | 0.112 0.005 DBMET02807 | DBMET02807 | |
| 0.01 | 0.16 | 0.105 | Factor Xa inhibitor | 0.105 0.013 DBMET02807 | DBMET02807 | |
| 0.021 | 0.172 | 0.073 | Alpha-mannosidase inhibitor | 0.071 0.016 DBMET02808 0.059 0.028 DBMET02803 0.059 0.028 DBMET02804 0.073 0.015 DBMET02805 0.073 0.015 DBMET02806 | DBMET02806 | |
| 0.015 | 0.171 | 0.068 | Mannosidase inhibitor | 0.067 0.013 DBMET02808 0.049 0.027 DBMET02803 0.049 0.027 DBMET02804 0.068 0.013 DBMET02805 0.068 0.013 DBMET02806 | DBMET02806 | |
| 0.058 | 0.224 | 0.086 | CC chemokine 5 receptor agonist | 0.086 0.047 DBMET02807 | DBMET02807 | |
| 0.007 | 0.174 | 0.053 | Antidiuretic hormone antagonist | 0.053 0.022 DBMET01020 0.053 0.022 DBMET02802 | DBMET02802 | |
| 0.006 | 0.178 | 0.147 | Cholecystokinin antagonist | 0.147 0.005 DBMET02807 | DBMET02807 | |
| 0.12 | 0.3 | 0.246 | Vasodilator, peripheral | 0.219 0.155 DBMET01020 0.219 0.155 DBMET02802 0.246 0.13 DBMET02803 0.246 0.13 DBMET02804 0.218 0.156 DBMET02805 0.218 0.156 DBMET02806 | DBMET02804 | |
| 0.121 | 0.302 | 0.351 | Vasodilator, coronary | 0.351 0.055 DBMET02808 0.335 0.063 DBMET02805 0.335 0.063 DBMET02806 | DBMET02808 | |
| 0.077 | 0.258 | 0.276 | DNA methylase inhibitor | 0.276 0.036 DBMET02808 0.235 0.057 DBMET02805 0.235 0.057 DBMET02806 | DBMET02808 | |
| 0.079 | 0.263 | 0.225 | Interleukin 6 antagonist | 0.135 0.115 DBMET01020 0.135 0.115 DBMET02802 0.225 0.029 DBMET02808 0.177 0.057 DBMET02805 0.177 0.057 DBMET02806 | DBMET02808 | |
| 0.047 | 0.233 | 0.313 | Amylase inhibitor | 0.313 0.017 DBMET02808 0.106 0.092 DBMET02803 0.106 0.092 DBMET02804 0.274 0.022 DBMET02805 0.274 0.022 DBMET02806 | DBMET02808 | |
| 0.071 | 0.262 | 0.249 | DNA methyltransferase I inhibitor | 0.249 0.047 DBMET02808 0.135 0.123 DBMET02805 0.135 0.123 DBMET02806 | DBMET02808 | |
| 0.004 | 0.197 | 0.027 | RNA-directed RNA polymerase stimulant | 0.027 0.023 DBMET01020 0.027 0.023 DBMET02802 | DBMET02802 | |
| 0.024 | 0.224 | 0.079 | Carbonic anhydrase XIII inhibitor | 0.079 0.051 DBMET02807 | DBMET02807 | |
| 0.016 | 0.218 | 0.054 | Neuraminidase (Influenza A) inhibitor | 0.054 0.019 DBMET02808 0.046 0.031 DBMET02805 0.046 0.031 DBMET02806 | DBMET02808 | |
| 0.062 | 0.266 | 0.228 | Diuretic | 0.133 0.092 DBMET02808 0.228 0.035 DBMET02805 0.228 0.035 DBMET02806 | DBMET02806 | |
| 0.117 | 0.324 | 0.409 | Peptidyltransferase inhibitor | 0.219 0.078 DBMET01020 0.219 0.078 DBMET02802 0.383 0.008 DBMET02808 0.242 0.056 DBMET02803 0.242 0.056 DBMET02804 0.409 0.006 DBMET02805 0.409 0.006 DBMET02806 | DBMET02806 | |
| 0.053 | 0.262 | 0.098 | Phosphodiesterase 6D inhibitor | 0.098 0.057 DBMET02808 | DBMET02808 | |
| 0.068 | 0.295 | 0.292 | NOS3 expression enhancer | 0.138 0.086 DBMET01020 0.138 0.086 DBMET02802 0.292 0.019 DBMET02808 0.259 0.025 DBMET02805 0.259 0.025 DBMET02806 | DBMET02808 | |
| 0.04 | 0.268 | 0.234 | AMP-activated protein kinase stimulant | 0.208 0.01 DBMET02808 0.234 0.008 DBMET02805 0.234 0.008 DBMET02806 | DBMET02806 | |
| 0.027 | 0.257 | 0.101 | Histone deacetylase stimulant | 0.101 0.027 DBMET02808 0.073 0.052 DBMET02805 0.073 0.052 DBMET02806 | DBMET02808 | |
| 0.027 | 0.257 | 0.101 | Histone deacetylase SIRT1 stimulant | 0.101 0.027 DBMET02808 0.073 0.052 DBMET02805 0.073 0.052 DBMET02806 | DBMET02808 | |
| 0.033 | 0.264 | 0.358 | Topoisomerase II inhibitor | 0.24 0.026 DBMET02808 0.358 0.013 DBMET02805 0.358 0.013 DBMET02806 | DBMET02806 | |
| 0.036 | 0.268 | 0.13 | Uric acid excretion stimulant | 0.13 0.032 DBMET02808 0.094 0.06 DBMET02805 0.094 0.06 DBMET02806 | DBMET02808 | |
| 0.001 | 0.237 | 0.013 | Antibiotic Macrolide-like | 0.013 0.011 DBMET02805 0.013 0.011 DBMET02806 | DBMET02806 | |
| 0.004 | 0.244 | 0.278 | Cholecystokinin agonist | 0.278 0.003 DBMET02807 | DBMET02807 | |
| 0.044 | 0.286 | 0.116 | Protein kinase C nu inhibitor | 0.116 0.098 DBMET01020 0.116 0.098 DBMET02802 | DBMET02802 | |
| 0.005 | 0.247 | 0.174 | Cholecystokinin A agonist | 0.174 0.003 DBMET02807 | DBMET02807 | |
| 0.039 | 0.282 | 0.302 | Thrombolytic | 0.156 0.077 DBMET02807 0.272 0.029 DBMET02808 0.302 0.024 DBMET02805 0.302 0.024 DBMET02806 | DBMET02806 | |
| 0.007 | 0.253 | 0.077 | Estrogen agonist | 0.077 0.024 DBMET02807 | DBMET02807 | |
| 0.005 | 0.253 | 0.05 | Sodium/glucose cotransporter 2 inhibitor | 0.05 0.006 DBMET02808 0.024 0.023 DBMET02805 0.024 0.023 DBMET02806 | DBMET02808 | |
| 0.087 | 0.335 | 0.472 | Transcription factor NF kappa B inhibitor | 0.472 0.049 DBMET02808 0.453 0.052 DBMET02805 0.453 0.052 DBMET02806 | DBMET02808 | |
| 0.042 | 0.291 | 0.089 | Lanosterol 14 alpha demethylase inhibitor | 0.089 0.074 DBMET02803 0.089 0.074 DBMET02804 | DBMET02804 | |
| 0.05 | 0.299 | 0.57 | Anticoagulant | 0.57 0.007 DBMET02807 0.229 0.044 DBMET02808 0.248 0.039 DBMET02805 0.248 0.039 DBMET02806 | DBMET02807 | |
| 0.091 | 0.342 | 0.387 | Alpha-glucosidase inhibitor | 0.387 0.121 DBMET02808 0.26 0.181 DBMET02805 0.26 0.181 DBMET02806 | DBMET02808 | |
| 0.004 | 0.256 | 0.201 | Cholecystokinin A antagonist | 0.201 0.005 DBMET02807 | DBMET02807 | |
| 0.021 | 0.276 | 0.087 | Heparanase inhibitor | 0.087 0.005 DBMET02808 0.078 0.007 DBMET02805 0.078 0.007 DBMET02806 | DBMET02808 | |
| 0.096 | 0.356 | 0.567 | Antithrombotic | 0.567 0.02 DBMET02808 0.565 0.02 DBMET02805 0.565 0.02 DBMET02806 | DBMET02808 | |
| 0.076 | 0.347 | 0.24 | ATPase inhibitor | 0.24 0.016 DBMET02808 0.187 0.05 DBMET02805 0.187 0.05 DBMET02806 | DBMET02808 | |
| 0.064 | 0.337 | 0.329 | Hemostatic | 0.184 0.04 DBMET02807 0.248 0.022 DBMET02808 0.329 0.013 DBMET02805 0.329 0.013 DBMET02806 | DBMET02806 | |
| 0.006 | 0.282 | 0.053 | Sodium/glucose cotransporter inhibitor | 0.053 0.005 DBMET02808 0.027 0.015 DBMET02805 0.027 0.015 DBMET02806 | DBMET02808 | |
| 0.027 | 0.314 | 0.257 | DNA intercalator | 0.136 0.049 DBMET02808 0.257 0.015 DBMET02805 0.257 0.015 DBMET02806 | DBMET02806 | |
| 0.013 | 0.305 | 0.349 | Cholecystokinin B agonist | 0.349 0.003 DBMET02807 | DBMET02807 | |
| 0.009 | 0.302 | 0.045 | Aldose reductase inhibitor | 0.045 0.044 DBMET02808 | DBMET02808 | |
| 0.024 | 0.321 | 0.051 | Factor III inhibitor | 0.051 0.031 DBMET02808 | DBMET02808 | |
| 0.081 | 0.381 | 0.181 | Hypoxia-inducible factor 1 alpha inhibitor | 0.181 0.177 DBMET02805 0.181 0.177 DBMET02806 | DBMET02806 | |
| 0.032 | 0.334 | 0.062 | Lipocortins synthesis agonist | 0.062 0.032 DBMET02808 0.06 0.035 DBMET02805 0.06 0.035 DBMET02806 | DBMET02808 | |
| 0.008 | 0.319 | 0.055 | Factor XIa inhibitor | 0.055 0.015 DBMET02807 | DBMET02807 | |
| 0.052 | 0.368 | 0.496 | Free radical scavenger | 0.496 0.017 DBMET02808 0.415 0.026 DBMET02805 0.415 0.026 DBMET02806 | DBMET02808 | |
| 0.012 | 0.344 | 0.114 | Elastase inhibitor | 0.114 0.007 DBMET02807 | DBMET02807 | |
| 0.017 | 0.36 | 0.091 | Thrombin inhibitor | 0.091 0.031 DBMET02807 | DBMET02807 | |
| 0.018 | 0.362 | 0.269 | Topoisomerase II alpha inhibitor | 0.143 0.024 DBMET02808 0.269 0.009 DBMET02805 0.269 0.009 DBMET02806 | DBMET02806 | |
| 0.012 | 0.362 | 0.032 | Toll-Like receptor 4 agonist | 0.027 0.016 DBMET02807 0.032 0.009 DBMET02808 0.032 0.01 DBMET02805 0.032 0.01 DBMET02806 | DBMET02806 | |
| 0.103 | 0.469 | 0.756 | Cyclophilin D inhibitor | 0.363 0.113 DBMET01020 0.363 0.113 DBMET02802 0.727 0.012 DBMET02808 0.345 0.125 DBMET02803 0.345 0.125 DBMET02804 0.756 0.009 DBMET02805 0.756 0.009 DBMET02806 | DBMET02806 | |
| 0.097 | 0.482 | 0.487 | Apoptosis agonist | 0.486 0.079 DBMET02808 0.487 0.078 DBMET02805 0.487 0.078 DBMET02806 | DBMET02806 | |
| 0.041 | 0.433 | 0.116 | Interleukin 4 antagonist | 0.116 0.091 DBMET02808 0.11 0.101 DBMET02805 0.11 0.101 DBMET02806 | DBMET02808 | |
| 0.021 | 0.418 | 0.087 | Gastric antisecretory | 0.087 0.083 DBMET02803 0.087 0.083 DBMET02804 | DBMET02804 | |
| 0.007 | 0.426 | 0.073 | HIV-1 integrase (Strand Transfer) inhibitor | 0.073 0.034 DBMET02803 0.073 0.034 DBMET02804 | DBMET02804 | |
| 0.024 | 0.444 | 0.109 | Multidrug resistance-associated protein 1 inhibitor | 0.109 0.063 DBMET02807 0.104 0.072 DBMET02805 0.104 0.072 DBMET02806 | DBMET02807 | |
| 0.004 | 0.434 | 0.035 | Factor XI inhibitor | 0.035 0.022 DBMET02807 | DBMET02807 | |
| 0.019 | 0.455 | 0.2 | Cell adhesion molecule inhibitor | 0.2 0.009 DBMET02807 0.115 0.026 DBMET02808 0.099 0.035 DBMET02805 0.099 0.035 DBMET02806 | DBMET02807 | |
| 0.037 | 0.476 | 0.338 | Platelet adhesion inhibitor | 0.328 0.025 DBMET02808 0.338 0.023 DBMET02805 0.338 0.023 DBMET02806 | DBMET02806 | |
| 0.029 | 0.471 | 0.135 | DNA polymerase I inhibitor | 0.102 0.084 DBMET01020 0.102 0.084 DBMET02802 0.117 0.071 DBMET02808 0.135 0.058 DBMET02805 0.135 0.058 DBMET02806 | DBMET02806 | |
| 0.04 | 0.482 | 0.094 | Interleukin 12 antagonist | 0.094 0.065 DBMET02808 | DBMET02808 | |
| 0.007 | 0.467 | 0.06 | Neuraminidase inhibitor | 0.06 0.044 DBMET02808 | DBMET02808 | |
| 0.079 | 0.548 | 0.14 | CC chemokine 6 receptor antagonist | 0.137 0.047 DBMET02808 0.14 0.04 DBMET02805 0.14 0.04 DBMET02806 | DBMET02806 | |
| 0.029 | 0.499 | 0.109 | Vanilloid agonist | 0.109 0.025 DBMET02807 | DBMET02807 | |
| 0.009 | 0.483 | 0.071 | Neuraminidase (influenza) inhibitor | 0.071 0.034 DBMET02808 0.064 0.044 DBMET02805 0.064 0.044 DBMET02806 | DBMET02808 | |
| 0.012 | 0.496 | 0.065 | Nitric oxide donor | 0.065 0.04 DBMET02805 0.065 0.04 DBMET02806 | DBMET02806 | |
| 0.022 | 0.516 | 0.098 | Thioredoxin inhibitor | 0.098 0.05 DBMET02808 | DBMET02808 | |
| 0.054 | 0.556 | 0.524 | Immunomodulator | 0.191 0.174 DBMET01020 0.191 0.174 DBMET02802 0.335 0.065 DBMET02808 0.524 0.02 DBMET02805 0.524 0.02 DBMET02806 | DBMET02806 | |
| 0.032 | 0.537 | 0.138 | Transcription factor NF kappa B stimulant | 0.118 0.026 DBMET02808 0.138 0.019 DBMET02805 0.138 0.019 DBMET02806 | DBMET02806 | |
| 0.022 | 0.532 | 0.642 | Angiogenesis stimulant | 0.462 0.014 DBMET02807 0.642 0.005 DBMET02808 0.598 0.007 DBMET02805 0.598 0.007 DBMET02806 | DBMET02808 | |
| 0.021 | 0.54 | 0.063 | Adenine nucleotide translocase inhibitor | 0.063 0.024 DBMET02808 0.059 0.031 DBMET02805 0.059 0.031 DBMET02806 | DBMET02808 | |
| 0.024 | 0.546 | 0.207 | Cell adhesion inhibitor | 0.157 0.042 DBMET02807 0.207 0.023 DBMET02808 0.199 0.025 DBMET02805 0.199 0.025 DBMET02806 | DBMET02808 | |
| 0.025 | 0.554 | 0.151 | Toll-Like receptor 4 antagonist | 0.151 0.02 DBMET02808 0.146 0.023 DBMET02805 0.146 0.023 DBMET02806 | DBMET02808 | |
| 0.05 | 0.602 | 0.113 | Sphingosine 1-phosphate receptor 2 agonist | 0.113 0.067 DBMET01020 0.113 0.067 DBMET02802 | DBMET02802 | |
| 0.012 | 0.581 | 0.072 | Glucose-6-phosphate translocase inhibitor | 0.072 0.015 DBMET02808 0.06 0.024 DBMET02805 0.06 0.024 DBMET02806 | DBMET02808 | |
| 0.009 | 0.594 | 0.109 | Protein 50S ribosomal subunit inhibitor | 0.094 0.015 DBMET02808 0.109 0.011 DBMET02805 0.109 0.011 DBMET02806 | DBMET02806 | |
| 0.004 | 0.604 | 0.023 | Motilin receptor agonist | 0.023 0.015 DBMET02805 0.023 0.015 DBMET02806 | DBMET02806 | |
| 0.003 | 0.625 | 0.038 | 1,3-Beta-glucan synthase inhibitor | 0.038 0.005 DBMET02807 | DBMET02807 | |
| 0.013 | 0.65 | 0.115 | ATPase (Vacuolar H+) inhibitor | 0.115 0.023 DBMET02808 0.097 0.044 DBMET02805 0.097 0.044 DBMET02806 | DBMET02808 | |
| 0.027 | 0.67 | 0.392 | Immunosuppressant | 0.382 0.071 DBMET02808 0.392 0.066 DBMET02805 0.392 0.066 DBMET02806 | DBMET02806 | |
| 0.041 | 0.719 | 0.409 | Apoptosis antagonist | 0.222 0.155 DBMET01020 0.222 0.155 DBMET02802 0.366 0.049 DBMET02808 0.409 0.036 DBMET02805 0.409 0.036 DBMET02806 | DBMET02806 | |
| 0.015 | 0.701 | 0.279 | Vasodilator | 0.211 0.096 DBMET02808 0.279 0.056 DBMET02805 0.279 0.056 DBMET02806 | DBMET02806 | |
| 0.01 | 0.704 | 0.259 | Platelet antagonist | 0.221 0.087 DBMET02808 0.259 0.068 DBMET02805 0.259 0.068 DBMET02806 | DBMET02806 | |
| 0.039 | 0.744 | 0.252 | Caspase 3 stimulant | 0.194 0.178 DBMET02808 0.252 0.111 DBMET02805 0.252 0.111 DBMET02806 | DBMET02806 | |
| 0.011 | 0.789 | 0.216 | Insulin secretagoues | 0.193 0.04 DBMET02808 0.216 0.029 DBMET02805 0.216 0.029 DBMET02806 | DBMET02806 | |
| 0.011 | 0.801 | 0.126 | Factor IXa inhibitor | 0.126 0.005 DBMET02807 0.087 0.014 DBMET02808 0.072 0.019 DBMET02805 0.072 0.019 DBMET02806 | DBMET02807 | |
| 0.017 | 0.82 | 0.541 | Hypoglycemic | 0.541 0.012 DBMET02808 0.508 0.014 DBMET02805 0.508 0.014 DBMET02806 | DBMET02808 | |
| 0.004 | 0.818 | 0.338 | Selectin antagonist | 0.193 0.012 DBMET02807 0.338 0.004 DBMET02808 0.335 0.004 DBMET02805 0.335 0.004 DBMET02806 | DBMET02808 | |
| 0.007 | 0.853 | 0.274 | Tumour necrosis factor alpha release inhibitor | 0.274 0.064 DBMET02808 0.17 0.134 DBMET02805 0.17 0.134 DBMET02806 | DBMET02808 | |
| 0.005 | 0.917 | 0.168 | Hypolipemic | 0.168 0.12 DBMET02805 0.168 0.12 DBMET02806 | DBMET02806 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |